BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 31, 2007
View Archived Issues
Allos Brings In $54M To Fund Pivotal Trials Of PDX, Efaproxyn
Allos Therapeutics Inc. is raising $54 million to fund development of its late-stage cancer compounds. (BioWorld Today)
Read More
Amylin, PsychoGenics Focus On CNS Drugs Via New Firm, Psylin
Read More
FDA Releases New Drug Safety Strategies To Improve Oversight
Read More
Lexicon Trims Staff, Spending To Boost Clinical Ambitions
Read More
Ception Closes $63M Series C For Anti-Inflammatory Trials
Read More
Other News To Note
Read More
Clinic Roundup
Read More